Glucocorticoids in <i>Systemic Lupus Erythematosus</i>. Ten Questions and Some Issues

Glucocorticoids in <i>Systemic Lupus Erythematosus</i>. Ten Questions and Some Issues

Since the discovery of glucocorticoids (GCs), their important anti-inflammatory effect, rapid mechanism of action, low cost, and accessibility have made them one of the mainstays of treatment for <i>Systemic lupus erythematosus</i> (SLE). Although their use has allowed controlling the di...

Full description

Bibliographic Details
Main Authors: Sabrina Porta, Alvaro Danza, Maira Arias Saavedra, Adriana Carlomagno, María Cecilia Goizueta, Florencia Vivero, Guillermo Ruiz-Irastorza
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
systemic lupus erythematosus
SLE
prednisone
methylprednisolone
glucocorticoids
mortality
Online Access:https://www.mdpi.com/2077-0383/9/9/2709

Internet

https://www.mdpi.com/2077-0383/9/9/2709

Similar Items